The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Archetypal NOTCH3 mutations frequent in public exome: implications for CADASIL
Open accessAbstract
Objective: To determine the frequency of distinctive EGF r cysteine altering NOTCH 3 mutations in the 60,706 exomes of the exome aggregation consortium (Ex AC) database. Methods: Ex AC was queried for mutations distinctive for cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), namely mutations leading to a cysteine amino acid change in one of the 34 EGF r domains of NOTCH 3. The genotype‐phenotype correlation predicted by the Ex AC data was tested in an independent cohort of Dutch CADASIL patients using quantified MRI lesions. The Dutch CADASIL registry was probed for paucisymptomatic individuals older than 70 years. Results: We identified 206 EGF r cysteine altering NOTCH 3 mutations in Ex AC, with a total prevalence of 3.4/1000. More than half of the distinct mutations have been previously reported in CADASIL patients. Despite the clear overlap, the mutation distribution in Ex AC differs from that in reported CADASIL patients, as mutations in Ex AC are predominantly located outside of EGF r domains 1–6. In an independent Dutch CADASIL cohort, we found that patients with a mutation in EGF r domains 7–34 have a significantly lower MRI lesion load than patients with a mutation in EGF r domains 1–6. Interpretation: The frequency of EGF r cysteine altering NOTCH 3 mutations is 100‐fold higher than expected based on estimates of CADASIL prevalence. This challenges the current CADASIL disease paradigm, and suggests that certain mutations may more frequently cause a much milder phenotype, which may even go clinically unrecognized. Our data suggest that individuals with a mutation located in EGF r domains 1–6 are predisposed to the more severe “classical” CADASIL phenotype, whereas individuals with a mutation outside of EGF r domains 1–6 can remain paucisymptomatic well into their eighth decade.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia
Joutel, A., Corpechot, C., Ducros, A., Vahedi, K., Chabriat, H., Mouton, P., Alamowitch, S., Domenga, V., Cécillion, M., Maréchal, E., et al. (1996) · Nature · doi:10.1038/383707a0 · Cited by 2,068
Chabriat, H., Joutel, A., Dichgans, M., Tournier-Lasserve, E., & Bousser, M.-G. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70127-9 · Cited by 1,088
Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients
Joutel, A., Vahedi, K., Corpechot, C., Troesch, A., Chabriat, H., Vayssière, C., Cruaud, C., Maciazek, J., Weissenbach, J., Bousser, M.-G., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)08083-5 · Cited by 682
Quantifying prion disease penetrance using large population control cohorts
Minikel, E. V., Vallabh, S. M., Lek, M., Estrada, K., Samocha, K. E., Sathirapongsasuti, J. F., McLean, C. Y., Tung, J. Y., Yu, L. P. C., Gambetti, P., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad5169 · Cited by 442
Patterns of MRI lesions in CADASIL
Chabriat, H., Levy, C., Taillia, H., Iba-Zizen, M.-T., Vahedi, K., Joutel, A., Tournier-Lasserve, E., & Bousser, M.-G. (1998) · Neurology · doi:10.1212/wnl.51.2.452 · Cited by 339
Adib-Samii, P., Brice, G., Martin, R. J., & Markus, H. S. (2010) · Stroke · doi:10.1161/strokeaha.109.568402 · Cited by 239
Cerebral microbleeds in CADASIL
Lesnik Oberstein, S. A. J., van den Boom, R., van Buchem, M. A., van Houwelingen, H. C., Bakker, E., Vollebregt, E., Ferrari, M. D., Breuning, M. H., & Haan, J. (2001) · Neurology · doi:10.1212/wnl.57.6.1066 · Cited by 218
Lacunar lesions are independently associated with disability and cognitive impairment in CADASIL
Viswanathan, A., Gschwendtner, A., Guichard, J. P., Buffon, F., Cumurciuc, R., O'Sullivan, M., Holtmannspötter, M., Pachai, C., Bousser, M. G., Dichgans, M., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000265221.05610.70 · Cited by 155
Brain volume changes in CADASIL: A serial MRI study in pure subcortical ischemic vascular disease
Peters, N., Holtmannspötter, M., Opherk, C., Gschwendtner, A., Herzog, J., Sämann, P., & Dichgans, M. (2006) · Neurology · doi:10.1212/01.wnl.0000216271.96364.50 · Cited by 130
Quantitative MRI in CADASIL: Correlation with disability and cognitive performance
Dichgans, M., Filippi, M., Brüning, R., Iannucci, G., Berchtenbreiter, C., Minicucci, L., Uttner, I., Crispin, A., Ludwig, H., Gasser, T., et al. (1999) · Neurology · doi:10.1212/wnl.52.7.1361 · Cited by 120
MRI correlates of cognitive decline in CADASIL: A 7-year follow-up study
Liem, M. K., Lesnik Oberstein, S. A. J., Haan, J., van der Neut, I. L., Ferrari, M. D., van Buchem, M. A., Middelkoop, H. A. M., & van der Grond, J. (2009) · Neurology · doi:10.1212/01.wnl.0000339038.65508.96 · Cited by 104
Cited by
Epidemiology, aetiology, and management of ischaemic stroke in young adults
Ekker, M. S., Boot, E. M., Singhal, A. B., Tan, K. S., Debette, S., Tuladhar, A. M., & de Leeuw, F.-E. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30233-3 · Cited by 496
Bushnell, C., Kernan, W. N., Sharrief, A. Z., Chaturvedi, S., Cole, J. W., Cornwell, W. K., Cosby-Gaither, C., Doyle, S., Goldstein, L. B., Lennon, O., et al. (2024) · Stroke · doi:10.1161/str.0000000000000475 · Cited by 360
The pathology and pathophysiology of vascular dementia
Kalaria, R. N. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.030 · Cited by 339
Rutten, J. W., Van Eijsden, B. J., Duering, M., Jouvent, E., Opherk, C., Pantoni, L., Federico, A., Dichgans, M., Markus, H. S., Chabriat, H., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-018-0088-3 · Cited by 169
Self-citationHack, R. J., Gravesteijn, G., Cerfontaine, M. N., Santcroos, M. A., Gatti, L., Kopczak, A., Bersano, A., Duering, M., Rutten, J. W., & Lesnik Oberstein, S. A. J. (2023) · Brain · doi:10.1093/brain/awac486 · Cited by 60
Self-citation
Metadata
- Authors
- Rutten, J. W., Dauwerse, H. G., Gravesteijn, G., van Belzen, M. J., van der Grond, J., Polke, J. M., Bernal‐Quiros, M., & Lesnik Oberstein, S. A. J.
- Venue
- Annals of Clinical and Translational Neurology
- Publisher
- Wiley
- Published
- 2016-09-28
- Volume
- 3
- Issue
- 11
- Pages
- 844-853
- ISSN
- 2328-9503 (ISSN-L)
- OpenAlex
- W2525619248
- Cited by
- 200
- References
- 11
- FWCI
- 5.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.